Wolff Wiese Magana LLC Novartis Ag Transaction History

Wolff Wiese Magana LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 26, 2022	SELL	$74.61 - $87.26 $9,326 - $10,907	-125 Reduced 61.58%	78 $6,000
Q4 2021 Jan 18, 2022	BUY	$79.7 - $88.13 $2,709 - $2,996	34 Added 20.12%	203 $18,000
Q3 2021 Oct 15, 2021	BUY	$81.78 - $95.14 $5,315 - $6,184	65 Added 62.5%	169 $14,000
Q2 2021 Jul 15, 2021	SELL	$85.24 - $94.15 $5,114 - $5,649	-60 Reduced 36.59%	104 $9,000
Q1 2021 Apr 15, 2021	BUY	$83.5 - $98.47 $1,252 - $1,477	15 Added 10.07%	164 $14,000
Q4 2020 Jan 27, 2021	BUY	$78.07 - $94.43 $11,632 - $14,070	149 New	149 $14,000

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Wolff Wiese Magana LLC, based on Form 13F filings with the SEC.

Stay updated on Wolff Wiese Magana LLC with notifications on news.